Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (221-230 of 775) with videos related to

Pageof 78
Sort By:
International Review of Psychiatry (Abingdon, England)|January 16, 2014
The Women's Healthy Ageing Project: fertile ground for investigation of healthy participants 'at risk' for dementiaCassandra E I Szoeke, Joanne S Robertson, Christopher C Rowe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2025
Exploring epidemiological risk factors for cerebral amyloid angiopathy: Considerations for monoclonal antibody therapy in people with Alzheimer's diseaseLiwei Ma, Yihan Wang, Andrew Liem Hieu Huynh, et al.
Communicable Diseases Intelligence (2018)|July 28, 2021
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2020Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2021
Relationship between amyloid and tau levels and its impact on tau spreadingVincent Doré, Natasha Krishnadas, Pierrick Bourgeat, et al.
Biochemistry|February 15, 2007
Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptideDavid P Smith, Giuseppe D Ciccotosto, Deborah J Tew, et al.
Expert Opinion on Medical Diagnostics|March 19, 2013
Advances in molecular imaging for the diagnosis of dementiaNobuyuki Okamura, Michelle T Fodero-Tavoletti, Yukitsuka Kudo, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 21, 2024
Exploring the link between comorbidities and Alzheimer's dementia in the Australian Imaging, Biomarker & Lifestyle (AIBL) studyCatherine Quynh Nhu Nguyen, Liwei Ma, Yi Ling Clare Low, et al.
Neurobiology of Disease|March 29, 2011
Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor proteinClaudia Santosa, Stefanie Rasche, Adel Barakat, et al.
The Australian and New Zealand Journal of Psychiatry|March 8, 2022
Cerebrospinal fluid Alzheimer disease biomarkers for assessing cognitive and neuropsychiatric symptoms: Expanding the 'toolkit' in the psychiatrist's diagnostic armamentariumDhamidhu Eratne, Qiao-Xin Li, Samantha M Loi, et al.
Neurobiology of Disease|June 23, 2004
APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer diseaseAmee J George, R M Damian Holsinger, Catriona A McLean, et al.
Pageof 78

Showing results (221-230 of 775) with videos related to

Sort By:
Pageof 78
International Review of Psychiatry (Abingdon, England)|January 16, 2014
The Women's Healthy Ageing Project: fertile ground for investigation of healthy participants 'at risk' for dementiaCassandra E I Szoeke, Joanne S Robertson, Christopher C Rowe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2025
Exploring epidemiological risk factors for cerebral amyloid angiopathy: Considerations for monoclonal antibody therapy in people with Alzheimer's diseaseLiwei Ma, Yihan Wang, Andrew Liem Hieu Huynh, et al.
Communicable Diseases Intelligence (2018)|July 28, 2021
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2020Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2021
Relationship between amyloid and tau levels and its impact on tau spreadingVincent Doré, Natasha Krishnadas, Pierrick Bourgeat, et al.
Biochemistry|February 15, 2007
Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptideDavid P Smith, Giuseppe D Ciccotosto, Deborah J Tew, et al.
Expert Opinion on Medical Diagnostics|March 19, 2013
Advances in molecular imaging for the diagnosis of dementiaNobuyuki Okamura, Michelle T Fodero-Tavoletti, Yukitsuka Kudo, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 21, 2024
Exploring the link between comorbidities and Alzheimer's dementia in the Australian Imaging, Biomarker & Lifestyle (AIBL) studyCatherine Quynh Nhu Nguyen, Liwei Ma, Yi Ling Clare Low, et al.
Neurobiology of Disease|March 29, 2011
Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor proteinClaudia Santosa, Stefanie Rasche, Adel Barakat, et al.
The Australian and New Zealand Journal of Psychiatry|March 8, 2022
Cerebrospinal fluid Alzheimer disease biomarkers for assessing cognitive and neuropsychiatric symptoms: Expanding the 'toolkit' in the psychiatrist's diagnostic armamentariumDhamidhu Eratne, Qiao-Xin Li, Samantha M Loi, et al.
Neurobiology of Disease|June 23, 2004
APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer diseaseAmee J George, R M Damian Holsinger, Catriona A McLean, et al.
Pageof 78